CTO Conference 2015

About the CTO 2015 Clinical Trials Conference

On March 4-5, 2015, Clinical Trials Ontario brought together members of the clinical research community to advance discussions relevant to improving the clinical trials environment in Ontario and in Canada.

Missed the CTO 2015 Clinical Trials Conference? Click the links below to view the conference archives:

• CTO 2015 Clinical Trials Conference Program
• CTO 2015 Clinical Trials Conference Digest
• CTO 2015 Clinical Trials Conference Session Presentations
  • Session 1: Building a global system for excellence in clinical research
    • Building a global system for excellence in clinical research based on the values of integrity, inclusiveness, innovation and implementation
      by Dr. Greg Koski, Co-Founder and President & CEO, Alliance for Clinical Research Excellence and Safety (ACRES); Former Director, Office for Human Research Protections, US Department of Health and Human Services
  • Session 2: Developments in the clinical trials environment in Canada and Ontario

    • National Updates

      Working towards new Health Canada guidelines for clinical trials
      by Ms. Karen Arts, Executive Director, Canadian Cancer Clinical Trials Network (3CTN); Director, External Initiatives, 3CTN and Co-founder and Chair of the Board of Directors, Network of Networks (N2)

      Strengthening clinical trials for Canadians, and update on the Canadian Clinical Trials Coordinating Centre (CCTCC)
      by Dr. Shurjeel Choudhri, Senior Vice President and Head, Medical and Scientific Affairs, Bayer Inc.; Rx&D Representative, Canadian Clinical Trials Coordinating Centre

      The Canadian Clinical Trials Asset Map – an upcoming important tool for promoting clinical research in Canada
      by Ms. Elena Aminkova, Project Manager, Clinical Trials Asset Map

    • Provincial Updates

      The Strategy for Patient Oriented Research in Ontario
      by Dr. Vasanthi Srinivasan, Executive Director, Ontario Strategy for Patient-Oriented Research (SPOR) SUPPORT Unit

      Starting early: The EXCITE (Excellence in Clinical Innovation and Technology Evaluation) Pre-Market Program
      by Dr. Les Levin, Chief Scientific Officer, MaRS EXCITE

      Clinical Trials Ontario: another year of building together
      by Ms. Susan Marlin, President and CEO, Clinical Trials Ontario

  • Session 3: From the frontlines – investigator and investigative site experiences
    • The site landscape – a 360° view
      by Ms. Christine Pierre, Founder and President, Society for Clinical Research Sites
    • Trials and tribulations: a study chair’s perspective
      by Dr. Douglas Bradley, Senior Scientist and Clifford Nordal Chair in Sleep Apnea and Rehabilitation Research, Toronto Rehab-University Health Network, and Professor of Medicine and Director of the Division of Respirology, University of Toronto
    • Community-based research: successes and challenges
      by Dr. Ronnie Aronson, Endocrinologist; Executive Director, LMC Diabetes & Endocrinology
    • View from the coordinating centre: challenges and opportunities
      by Dr. Shamir Mehta, Professor of Medicine, McMaster University; Director, Interventional Cardiology, Acute Coronary Syndrome Research Program, Population Health Research Institute, Hamilton Health Sciences
  • Session 4: Participant engagement in clinical trials
    • CTO Update: Patient & Public Engagement
      by Dr. Dawn Richards, Patient Engagement Research Advisor, Clinical Trials Ontario
    • Engaging the public in clinical trials: why are clinical trials important and why should Canadians care?
      by Dr. Andreas Laupacis, Executive Director, Li Ka Shing Knowledge Institute, St. Michael’s Hospital
    • Health charities and participant engagement
      by Dr. Larry Chambers, Scientific Advisor to the Alzheimer Society of Canada; Professor, Department of Epidemiology and Community Medicine, Department of Family Medicine and School of Nursing, University of Ottawa; Past-President and Chief Scientist of the Élisabeth Bruyère Research Institute
  • Workshop 1: Opportunities and challenges in recruiting patients and using patient data
    • Using routinely collected clinical data to support Clinical Trials: a view from Scotland
      by Dr. Colin McCowan, Professor of Health Informatics, Robertson Centre for Biostatistics, Institute of Health and Wellbeing, College of Medical, Veterinary and Life Sciences, University of Glasgow
    • Leveraging clinical trials through linkage to ICES administrative health data: an Ontario advantage
      by Dr. Michael Schull, President and CEO, Institute for Clinical Evaluative Sciences and Professor, Department of Medicine, University of Toronto
    • Randomized registry trials in Canada
      by Dr. E. Marc Jolicoeur, Associate Professor of Medicine, Université de Montréal; Interventional Cardiologist, Montreal Heart Institute
    • Conducting patient-oriented pragmatic trials in Ontario: opportunities and challenges
      by Dr. Dean A. Fergusson, Senior Scientist & Director, Clinical Epidemiology Program, Ottawa Hospital Research Institute
    • Clinical trials and administrative data: a marriage proposal
      by Dr. Annette Hay, Hematologist; Senior Investigator, NCIC Clinical Trials Group
    • TCPS 2 & Clinical Trials: What’s old – What’s new
      by Dr. Laura-Lee Balkwill, Policy Analyst, Secretariat on Responsible Conduct of Research
    • Research ethics: stop sign or signpost?
      by Dr. Don Willison, Associate Professor, Dalla Lana School of Public Health, Institute of Health Policy Management and Evaluation, Joint Centre for Bioethics; Associate Professor (part time) McMaster University, Department of Clinical Epidemiology and Biostatistics
  • Workshop 2: CTO Streamlined Research Ethics Review System
    • Implementing IT solutions for single ethical review in different countries
      by Mr. Mark Larson, CEO, Infonetica Ltd.
    • The long and winding road…ethics harmonization in British Columbia
      by Ms. Laurel Evans, Director, Research Ethics, University of British Columbia
    • Quebec Multicentre Framework
      by Dr. Diane Laflamme, Conseillère en éthique, Direction de l’éthique et de la qualité; Ministère de la Santé et des Services sociaux
    • CTO Streamlined Research Ethics Review System
      by Ms. Susan Marlin, Ms. Erin Bell, Mr. Matthew D’Ascanio, and Mr. Jessa Gill, CTO